Opus Genetics, Inc. (IRD) Total liabilities 2019–2025
Opus Genetics, Inc. (IRD) total liabilities at each fiscal year-end, per SEC filings.
$34.9MFY2025 · since FY2019: $9.3M → $34.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $34.9M | +208.9% |
| FY2024 | $11.3M | +179.4% |
| FY2023 | $4.0M | +46.8% |
| FY2022 | $2.8M | -28.6% |
| FY2021 | $3.9M | -87.6% |
| FY2020 | $31.1M | +233.4% |
| FY2019 | $9.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice